People
The Strategy is led by Mr. Baifeng Hu, CITIC CLSA Management Committee Member, Division Management of CITICS CLSA Capital Partners, who has a long-established career in private equity investment in Greater China.
Baifeng HuMr. Hu leads CITICS CLSA Capital Partners, the global alternative investment platform of CITIC Securities. He joined CITIC Securities in May 2014, and served in its onshore alternative investment platform Goldstone Investment Co., Ltd, as Deputy General Manager and Member of Investment Committee, and heads CITIC M&A Fund, the flagship PE fund of CITIC Securities.
Mr. Hu brings c. 20 years of investment experience, and has led and closed numerous private equity deals in healthcare, TMT, and high-end manufacturing sectors, and is equipped with rich knowledge in private equity and corporate leadership. Prior to joining CITIC Securities, Mr. Hu served as Head of Investment Division II and Member of Investment Committee in CDB Capital.
Mr. Hu holds leadership positions in top players of various strategically-important industries. He served as the Chairman of Ampleon, a global-leading semiconductor company headquartered in Netherland, and is currently Director of Pharmaron, a top-5 CRO company in the world.
Team Background
The team of China growth strategy comes from a wide range of professional backgrounds:
- 80% of the team hold a master / doctoral degree
- 80% are from PE/VC, the rest are from investment banking, legal and other financial services that bring complementary skill sets to the team
- Core senior executives working together for near 10 years